v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]    
Revenue $ 2,336 $ 679
Cost of revenue 6,781 4,196
Gross loss (4,445) (3,517)
Operating expenses:    
Research and development 1,581 800
Selling, general and administrative 4,293 5,434
Total operating expenses 5,874 6,234
Loss from operations (10,319) (9,751)
Other income 433 649
Net loss $ (9,886) $ (9,102)
Weighted-average common shares outstanding:    
Weighted-average common shares outstanding, basic (in shares) 90,029,320 84,645,097
Weighted-average common shares outstanding, diluted (in shares) 90,029,320 84,645,097
Net loss per share of common stock:    
Net loss per share of common stock, basic (in dollars per share) $ (0.11) $ (0.11)
Net loss per share of common stock, diluted (in dollars per share) $ (0.11) $ (0.11)

Source